Collectively, these results strongly suggest that compounds 1 and 2 exert their anti-influenza activity by inhibiting the PI3K-Akt signaling pathway and blocking viral RNP export from the nucleus, which are important in the viral replication step after virus infection. The gene discussed is RNPC3; the disease is viral infectious disease.